Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

409
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
409
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

228
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
228
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

641
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
641
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

519
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
519
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

267
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
267
Prevalence and Incidence01:08

Prevalence and Incidence

949
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
949

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuberculosis in Poland in 2022.

Przeglad epidemiologiczny·2025
Same author

Tuberculosis in Poland in 2021.

Przeglad epidemiologiczny·2024
Same author

Inventory study on completeness of tuberculosis case notifications in Poland in 2018.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024
Same author

Tuberculosis incidence in foreign-born people residing in European countries in 2020.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2023
Same author

Cladribine treatment in patients with pulmonary Langerhans cell histiocytosis.

Polish archives of internal medicine·2023
Same author

The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study.

Frontiers in public health·2023

Related Experiment Video

Updated: Oct 15, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

Tuberculosis in Poland in 2019.

Maria Korzeniewska-Koseła1, Stefan Wesołowski2

  • 1National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland Department of Tuberculosis Epidemiology and Surveillance.

Przeglad Epidemiologiczny
|October 26, 2021
PubMed
Summary
This summary is machine-generated.

Tuberculosis incidence in Poland decreased in 2019 compared to previous years, with lower rates of multidrug-resistant TB than the EU/EEA average. Higher incidence was observed in older age groups and men, with bacteriological confirmation rates exceeding EU/EEA averages.

Keywords:
MDR-TBTB confirmed by cultureTB incidencetuberculosis (TB)

More Related Videos

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
09:20

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear

Published on: July 3, 2025

670
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.5K

Related Experiment Videos

Last Updated: Oct 15, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K
Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
09:20

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear

Published on: July 3, 2025

670
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.5K

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a significant public health concern globally and within the European Union/European Economic Area (EU/EEA).
  • Understanding the specific epidemiological features of TB in individual countries is crucial for targeted control strategies.

Purpose of the Study:

  • To analyze the key epidemiological characteristics of tuberculosis in Poland in 2019.
  • To compare Poland's TB situation with that of other EU/EEA countries.

Main Methods:

  • Utilized national TB registry data for case-based analysis.
  • Included data on drug susceptibility, mortality (2018), HIV-positive TB cases, and EU/EEA surveillance reports.

Main Results:

  • Poland reported 5321 TB cases in 2019, with an incidence rate of 13.9 per 100,000 population.
  • Pulmonary TB constituted 95.4% of cases; bacteriological confirmation exceeded 75%, higher than the EU/EEA average.
  • Multidrug-resistant TB (MDR-TB) was less common (1.1% of cases) than the EU/EEA average. Incidence increased with age, with men showing a nearly threefold higher rate than women.

Conclusions:

  • TB incidence in Poland declined in 2019, with persistent regional variations.
  • Poland demonstrates a lower prevalence of MDR-TB and higher bacteriological confirmation rates compared to EU/EEA averages.
  • The study highlights significant disparities in TB incidence based on age and sex, with a minimal impact of migration on overall TB characteristics.